Report Overview

The Indian government’s initiatives to improve cancer care in the country, the rising burden of cancer, growing awareness about cancer in India, and growing adoption of advanced technologies are expected to drive the India Cancer Treatment Market during the forecast period between 2024 and 2030.

India Cancer Treatment Market – Industry Trends & Forecast Report, 2030

The India Cancer Treatment Market size was estimated at USD 4.21 billion in 2023. During the forecast period between 2024 and 2030, the India Cancer Treatment Market size is projected to grow at a CAGR of 8% reaching a value of USD 5.89 billion by 2030. A prominent driver of the market is an increasing rate of cancer cases, with an estimated 1.39 million cases in 2020 and over 0.8 million deaths in 2019, posing a significant public health concern. Notably, cervical cancer claims one woman's life every 8 minutes, and breast cancer mortality remains high. The surge in tobacco consumption further exacerbates cancer fatalities. Factors contributing to rising cases include dietary changes, food adulteration, and environmental factors. Sedentary lifestyles and junk food consumption also contribute to increasing cancer incidences. This underscores the pressing need for timely diagnosis and preventive care, driving substantial investments in R&D to develop more effective drugs. The Indian market offers promising opportunities for venture capitalists and investors, given the saturation of developed markets in the cancer treatment industry.

Cancer Treatment – Overview

Cancer treatment refers to the range of medical interventions and therapies aimed at diagnosing, managing, and curing cancer. These treatments may include surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, hormone therapy, stem cell transplantation, and precision medicine approaches. The goal of cancer treatment is to eliminate cancerous cells, prevent their spread, alleviate symptoms, prolong survival, and improve the quality of life for individuals affected by cancer. Treatment plans are often personalized based on factors such as the type and stage of cancer, the patient's overall health, and their preferences. Additionally, supportive care measures may be incorporated to help manage side effects and provide emotional and psychological support to patients and their families throughout the treatment process.

India Cancer Treatment Market

Growth Drivers

Government’s Initiatives to Improve Cancer Care in India

The Indian government is prioritizing initiatives to enhance cancer care nationwide. With a heightened focus on oncology at institutions like the All India Institute of Medical Sciences (AIIMS) and the implementation of effective cancer diagnosis and treatment under the Ayushman Bharat Scheme, significant strides are being made in improving healthcare services. Also, ongoing efforts to upgrade cancer care infrastructure across states, such as Madhya Pradesh, Odisha, and Maharashtra, are bolstering the availability of advanced treatments. These governmental endeavors are vital in addressing the rising burden of cancer and ensuring access to quality care for all patients across India.

Increasing Awareness about Cancer in India

Increasing awareness about cancer in India is crucial for comprehensive cancer care. While awareness levels about tobacco-related cancers are high, other common cancers like cervical cancer suffer from low awareness. It's imperative to educate the public about cancer causes, risk factors, early detection methods, and available treatment options. Highlighting factors such as Human papillomavirus (HPV), alcohol abuse, and obesity can aid in effective prevention strategies. Heightened awareness can lead to more early-stage diagnoses, necessitating the expansion of treatment facilities. Ultimately, raising awareness, promoting early detection, and implementing prevention measures can significantly reduce cancer rates, benefiting all stakeholders in the long run.

Challenges

High Cost of Treatment

The high cost of treatment serves as a significant barrier to the growth of the India Cancer Treatment Market. Uncertainties arising from geopolitical conflicts may disrupt the supply chain of crucial medical equipment, drugs, and resources necessary for cancer treatment. Additionally, heightened tensions may lead to economic instability, affecting healthcare budgets and investment in medical infrastructure and research. Import restrictions and trade barriers resulting from geopolitical conflicts can further exacerbate the situation, limiting access to essential cancer treatment technologies and medications. Overall, escalating geopolitical tensions pose significant challenges to the India Cancer Treatment Market, potentially impeding access to vital healthcare services for cancer patients.

Impact of Escalating Geopolitical Tensions on India Cancer Treatment Market

Geopolitical tensions can have a multifaceted impact on the India Cancer Treatment Market. Uncertainties arising from geopolitical conflicts may disrupt the supply chain of crucial medical equipment, drugs, and resources necessary for cancer treatment. Additionally, heightened tensions may lead to economic instability, affecting healthcare budgets and investment in medical infrastructure and research. Import restrictions and trade barriers resulting from geopolitical conflicts can further exacerbate the situation, limiting access to essential cancer treatment technologies and medications. Overall, escalating geopolitical tensions pose significant challenges to the India Cancer Treatment Market, potentially impeding access to vital healthcare services for cancer patients.

 India Cancer Treatment Market

Segmental Coverage

 India Cancer Treatment Market – By Treatment Type

By treatment type, the India Cancer Treatment Market is divided into Chemotherapy, Targeted Therapy, Immunotherapy, and Hormonal Therapy segments. The targeted therapy segment holds the highest share in the India Cancer Treatment Market by treatment type. It is attributed to their effectiveness in selectively targeting malignant cells and improving survival rates. Conversely, immunotherapy is projected to experience the highest growth due to increasing cancer incidences in India and limited medical resources. India's low-resource healthcare system often excludes expensive cancer medications from public reimbursement schemes, leading to financial burdens for patients. Therefore, a thorough evaluation of systemic anticancer therapies is essential before their inclusion in national formularies to mitigate expenditure risks and ensure equitable access to treatment.

India Cancer Treatment Market – By Drug Type

Based on drug type, the India Cancer Treatment Market is divided into Cytotoxic Drugs, Targeted Drugs, and Hormonal Drugs segments. The cytotoxic drugs segment holds the highest share in the India Cancer Treatment Market by drug type. The primary focus of top-priority medications lies in conventional cytotoxic therapy, encompassing well-known drugs like doxorubicin, cyclophosphamide, and paclitaxel, among others. These cytotoxic drugs have faced global competition from generics over the past two decades. Indian oncologists highly prioritize generic chemotherapy agents, which have been instrumental in enhancing survival rates and are already part of the WHO Essential Medicines List. These medications are esteemed for their effectiveness and accessibility in cancer treatment, making them indispensable in the eyes of Indian oncologists.

India Cancer Treatment Market – By Cancer Type

On the basis of cancer type, the India Cancer Treatment Market is divided into Blood Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Non-Hodgkin’s Cancer, and Respiratory/ Lung Cancer segments. The breast cancer segment holds the highest share in the India Cancer Treatment Market by cancer type. Breast cancer stands as a prevalent global and Indian health concern, exacerbated by insufficient awareness. Oncologists emphasize the importance of cancer literacy, particularly among women aged 40 to 60, advocating for regular screening to enable early detection and effective treatment. Meanwhile, the cervical cancer holds the highest share in the India Cancer Treatment Market by cancer type. It often linked to Human Papillomavirus (HPV) infection, affects 12% of Indian women, while oral cancer constitutes 7% of annual new cancer diagnoses. This underscores the necessity for heightened awareness campaigns and proactive screening initiatives to combat the rising incidence rates of these cancers and ensure timely interventions for improved patient outcomes.

India Cancer Treatment Market – By End User

By end user, the India Cancer Treatment Market is divided into Hospitals, Specialty Clinics, and Cancer & Radiation Therapy Centers segments.

India Cancer Treatment Market – By Region

Geographically, the India Cancer Treatment Market is divided into North India, South India, East India, and West India regions.

Competitive Landscape

Major players operating in India Cancer Treatment Market include Bayer, Astellas Pharma Inc., F. Hoffmann-La-Roche, Pfizer Limited, Natco Pharma, Novartis AG, Amgen, Merck KGaA, Siemens Healthineers, Bristol-Myers Squibb Company, Pinnacle Life Science Pvt Ltd, and Takeda Pharmaceuticals. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

• In February 2024 - The Tata Institute in Mumbai pioneered a revolutionary cancer treatment. After a decade of research, the institute announced that they had developed a tablet, 'R+Cu', that could prevent cancer recurrence and slash treatment side effects by 50%. The tablet contains pro-oxidant elements like resveratrol and copper, which generate oxygen radicals in the stomach, inhibiting cancer cell formation and metastasis. Although human trials are pending approval from the Food Safety and Standards Authority of India (FSSAI), the tablet could hit the market by June-July 2024, offering a game-changing, affordable treatment option at just INR 100, potentially transforming cancer care accessibility and effectiveness.

• In January 2024 - Mumbai-based BDR Pharmaceuticals introduced BDENZA oral solution for prostate cancer treatment, approved by the Drug Controller General of India (DCGI). Priced at INR 27,000 for 150 ml, it is approximately 8-10% of the cost of Enzalutamide capsules. BDENZA's liquid form offers flexibility in dosing adjustments and addresses taste or dietary restrictions. BDR emphasizes its paradigm shift in prostate cancer therapy, aiming to provide convenience, reduced side effects, and affordability, addressing the growing global concern of prostate cancer, particularly in India.

Scope of the Report

Attributes	Details
Years Considered	Historical Data – 2019–2030
	Base Year – 2023
	Estimated Year – 2024
	Forecast Period – 2024–2030
Facts Covered	USD Billion
Market Coverage	India
Product/ Service Segmentation	Treatment, Drug Type, Cancer Type, End User
Key Players	Bayer, Astellas Pharma Inc., F. Hoffmann-La-Roche, Pfizer Limited, Natco Pharma, Novartis AG, Amgen, Merck KGaA, Siemens Healthineers, Bristol-Myers Squibb Company, Pinnacle Life Science Pvt Ltd, Takeda Pharmaceuticals

 

By Treatment Type

• Chemotherapy

• Targeted Therapy

• Immunotherapy

• Hormonal Therapy

By Drug Type

• Cytotoxic Drugs

• Targeted Drugs

• Hormonal Drugs

By Cancer Type

• Blood Cancer

• Breast Cancer

• Colorectal Cancer

• Cervical Cancer

• Prostate Cancer

• Gastrointestinal Cancer

• Gynecologic Cancer

• Non-Hodgkin’s Cancer

• Respiratory/ Lung Cancer

By End User

• Hospitals

• Specialty Clinics

• Cancer & Radiation Therapy Centers

By Region

• North India

• South India

• East India

• West India

1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Market Segmentation
2. Executive Summary
3. India Cancer Treatment Market Insights
   1. Industry Value Chain Analysis
   2. DROC Analysis
      1. Growth Drivers
         1. Rising burden of cancer
         2. Increasing awareness about cancer in India
         3. Government initiatives to improve cancer care in the country
         4. Growing adoption of advanced technologies
      2. Restraints
         1. High cost of treatment
         2. Lack of infrastructure
         3. Shortage of skilled healthcare professionals
      3. Opportunities
         1. Increasing popularity for Ayurveda-based cancer medication and therapies
         2. Growing demand for affordable cancer care solutions in India.
         3. Growing healthcare insurance
      4. Challenges
         1. Presence of Counterfeit drugs:
         2. Lack of awareness about early detection
   3. Technological Advancements/Recent Developments
   4. Regulatory Framework
   5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
4. India Cancer Treatment Market: Pricing Analysis
5. India Cancer Treatment Market: Marketing Strategies
6. India Cancer Treatment Market Overview
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Treatment Type
         1. Chemotherapy
         2. Targeted Therapy
         3.  Immunotherapy
         4. Hormonal Therapy
         5. Others
      2. By Drug Type
         1. Cytotoxic Drugs
         2.  Targeted Drugs
         3.  Hormonal Drugs
         4. Others
      3. By Cancer Type
         1. Blood Cancer
         2. Breast Cancer
         3. Colorectal Cancer
         4.  Cervical Cancer
         5. Prostate Cancer
         6. Gastrointestinal Cancer
         7. Gynecologic Cancer
         8. Non-Hodgkin’s Cancer
         9. Respiratory/ Lung Cancer
         10. Others
      4. By End User
         1. Hospitals
         2. Specialty Clinics
         3.  Cancer and Radiation Therapy Centers
      5. By Region
         1. North India
         2. South India
         3. East India
         4. West India
7. North India Cancer Treatment Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Treatment Type
      2. By Drug Type
      3. By Cancer Type
      4. By End User
8. South India Cancer Treatment Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Treatment Type
      2. By Drug Type
      3. By Cancer Type
      4. By End User
9. East India Cancer Treatment Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Treatment Type
      2. By Drug Type
      3. By Cancer Type
      4. By End User
10. West India Cancer Treatment Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Treatment Type
       2. By Drug Type
       3. By Cancer Type
       4. By End User
11. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. India Cancer Treatment Company Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operation Channel Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
12. Impact of Escalating Geopolitical Tensions in India Cancer Treatment Market
13. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Bayer
    2. Astellas Pharma Inc.,
    3. F. Hoffmann- La- Roche
    4. Pfizer Limited
    5. Natco Pharma
    6. Novartis AG
    7. Amgen
    8. Merck KGaA
    9. Siemens Healthineers
    10. Bristol-Myers Squibb Company
    11. Pinnacle Life Science Pvt Ltd
    12. Takeda Pharmaceuticals
    13. Other Prominent Players
14. Key Strategic Recommendations
15. Research Methodology
    1. Qualitative Research
       1. Primary & Secondary Research
    2. Quantitative Research
    3. Market Breakdown & Data Triangulation
       1. Secondary Research
       2. Primary Research
    4. Breakdown of Primary Research Respondents, By Region
    5. Assumption & Limitation

 

*Financial information of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

 

List of Figures

 

Figure 1       India Cancer Treatment Market Segmentation                 

Figure 2       India Cancer Treatment Market Value Chain Analysis       

Figure 3       Company Market Share Analysis, 2023                                               

Figure 4       India Cancer Treatment Market Size, By Value (USD Billion), 2019–2030

Figure 5       India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019–2030

Figure 6       India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019–2030

Figure 7       India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019–2030

Figure 8       India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019–2030

Figure 9       India Cancer Treatment Market Share, By Region, By Value (USD Billion) 2019–2030

Figure 10     North India Cancer Treatment Market Size, By Value (USD Billion), 2019–2030

Figure 11     North India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019–2030

Figure 12     North India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019–2030

Figure 13     North India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019–2030

Figure 14     North India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019–2030

Figure 15     South India Cancer Treatment Market Size, By Value (USD Billion), 2019–2030

Figure 16     South India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019–2030

Figure 17     South India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019–2030

Figure 18     South India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019–2030

Figure 19     South India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019–2030

Figure 20     East India Cancer Treatment Market Size, By Value (USD Billion), 2019–2030

Figure 21     East India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019–2030

Figure 22     East India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019–2030

Figure 23     East India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019–2030

Figure 24     East India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019–2030

Figure 25     West India Cancer Treatment Market Size, By Value (USD Billion), 2019–2030

Figure 26     West India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019–2030

Figure 27     West India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019–2030 

Figure 28     West India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019–2030

Figure 29     West India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019–2030                                       

 

List of Tables      

 

Table 1        India Cancer Treatment Market Size, By Value (USD Billion), 2019–2030

Table 2        India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019–2030

Table 3        India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019–2030

Table 4        India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019–2030

Table 5        India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019–2030

Table 6        India Cancer Treatment Market Share, By Region, By Value (USD Billion) 2019–2030

Table 7        North India Cancer Treatment Market Size, By Value (USD Billion), 2019–2030

Table 8        North India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019–2030

Table 9        North India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019–2030

Table 10      North India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019–2030

Table 11      North India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019–2030

Table 12      South India Cancer Treatment Market Size, By Value (USD Billion), 2019–2030

Table 13      South India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019–2030

Table 14      South India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019–2030

Table 15      South India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019–2030

Table 16      South India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019–2030

Table 17      East India Cancer Treatment Market Size, By Value (USD Billion), 2019–2030

Table 18      East India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019–2030

Table 19      East India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019–2030

Table 20      East India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019–2030

Table 21      East India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019–2030

Table 22      West India Cancer Treatment Market Size, By Value (USD Billion), 2019–2030

Table 23      West India Cancer Treatment Market Share, By Treatment Type, By Value (USD Billion) 2019–2030

Table 24      West India Cancer Treatment Market Share, By Drug Type, By Value (USD Billion) 2019–2030 

Table 25      West India Cancer Treatment Market Share, By Cancer Type, By Value (USD Billion) 2019–2030

Table 26      West India Cancer Treatment Market Share, By End User, By Value (USD Billion) 2019–2030                                       

Table 27      Bayer Company Overview

Table 28      Bayer Company Overview

Table 29      Astellas Pharma Inc., Company Overview

Table 30      Astellas Pharma Inc., Company Overview

Table 31      F. Hoffmann- La- Roche Company Overview

Table 32      F. Hoffmann- La- Roche Company Overview

Table 33      Pfizer Limited Company Overview

Table 34      Pfizer Limited Company Overview

Table 35      Natco Pharma Company Overview

Table 36      Natco Pharma Company Overview

Table 37      Novartis AG Company Overview

Table 38      Novartis AG Company Overview

Table 39      Amgen Company Overview

Table 40      Amgen Company Overview

Table 41      Merck KGaA Company Overview

Table 42      Merck KGaA Company Overview

Table 43      Siemens Healthineers Company Overview

Table 44      Siemens Healthineers Company Overview

Table 45      Bristol-Myers Squibb Company Overview

Table 46      Bristol-Myers Squibb Company Overview

Table 47      Pinnacle Life Science Pvt Ltd Company Overview

Table 48      Pinnacle Life Science Pvt Ltd Company Overview

Table 49      Takeda Pharmaceuticals Company Overview

Table 50      Takeda Pharmaceuticals Company Overview